Now that the patent for the brand-name version has expired, generic Nasarel is available. It is sold under the name flunisolide nasal spray and contains 200 sprays in each bottle, with 29 mcg of medication in each spray. Generic Nasarel has been given an "AB" rating by the FDA, meaning it is considered equivalent to the brand-name version.
Nasarel™ (flunisolide nasal solution) is a prescription nasal spray used to treat nasal allergies (known medically as allergic rhinitis). It belongs to a group of medications known as corticosteroids (or simply "steroids" for short). It can be used in adults and children as young as six years old.
Nasarel is manufactured by Ivax Pharmaceuticals. However, the patents for the medication have expired, and generic Nasarel is now available.
Generic Nasarel is available in one strength -- flunisolide nasal spray, containing 200 sprays in each bottle, with 29 mcg of medication in each spray. Other strengths of flunisolide nasal spray (25 mcg per spray) are not equivalent to Nasarel. These products are equivalent to Nasalide®, a similar nasal spray.
Generic Nasarel is made by Apotex Corporation.
All generic medications must have certain tests that compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide whether the generic versions are equivalent to the brand-name medications and assigns a rating to each one. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic Nasarel versions currently available have an "AB" rating, meaning they should be equivalent to Nasarel.
However, generic medications are allowed to have different inactive ingredients from the brand-name medication. This might include fillers, dyes, or other ingredients, which may cause problems for people with certain allergies or sensitivities.